Agonist function of the neurokinin receptor antagonist, [D-Arg1,D-Phe5,D-Trp7,9,Leu11]substance P, in monocytes - PubMed (original) (raw)
Agonist function of the neurokinin receptor antagonist, [D-Arg1,D-Phe5,D-Trp7,9,Leu11]substance P, in monocytes
Angela Djanani et al. Regul Pept. 2003.
Abstract
G-protein-coupled bombesin receptors are capable of signaling through the G(i) protein even when receptor-coupling to G(q) is blocked by [D-Arg1,D-Phe5,D-Trp7,9,Leu11]substance P (SpD), a neurokinin-1 receptor antagonist and "biased" agonist to bombesin receptors. As bombesin is a monocyte and tumor cell attractant, we were interested in the effects of SpD on cell migration. Chemotaxis of monocytes was tested in micropore filter assays. SpD was a dose-dependent agonist in monocyte migration and was not inhibited by antagonists to neurokinin-1 or -2 receptors. SpD failed to inhibit chemotaxis toward bombesin, suggesting that inhibition of bombesin receptor coupling to G(q) with SpD does not impair migratory responses elicited by bombesin. As pertussis toxin inhibited migration, coupling of receptors to G(i) may signal migration. Chemotaxis toward SpD was inhibited by bombesin receptor antagonists as well as by blocking signaling enzymes downstream of G(q) (phospholipase-3 and protein kinase C with wortmannin and bisindolylmaleimide, respectively), suggesting transactivation of G(q)-mediated chemotaxis signaling by SpD via bombesin receptors. Protein kinase C that induces sphingosine kinase activation and production of sphingosine-1-phosphate, which may lead to G(q)-dependent chemoattraction, was involved in SpD-dependent migration. Inhibition of sphingosine-1-phosphate production with dimethylsphingosine inhibited monocyte migration toward SpD. Data suggest that SpD induces migration in monocytes and signaling events involving activation of sphingosine kinase in a G(i) protein- and protein kinase C-dependent fashion. "Biased" agonism of SpD at bombesin receptors may affect normal and tumor cell migration.
Similar articles
- Bombesin and substance P analogues differentially regulate G-protein coupling to the bombesin receptor. Direct evidence for biased agonism.
MacKinnon AC, Waters C, Jodrell D, Haslett C, Sethi T. MacKinnon AC, et al. J Biol Chem. 2001 Jul 27;276(30):28083-91. doi: 10.1074/jbc.M009772200. Epub 2001 Apr 25. J Biol Chem. 2001. PMID: 11323408 - The immune modulator FTY720 targets sphingosine-kinase-dependent migration of human monocytes in response to amyloid beta-protein and its precursor.
Kaneider NC, Lindner J, Feistritzer C, Sturn DH, Mosheimer BA, Djanani AM, Wiedermann CJ. Kaneider NC, et al. FASEB J. 2004 Aug;18(11):1309-11. doi: 10.1096/fj.03-1050fje. Epub 2004 Jun 18. FASEB J. 2004. PMID: 15208267 - Differential modulation of bombesin-stimulated phospholipase C beta and mitogen-activated protein kinase activity by [D-Arg1,D-Phe5,D-Trp7,9,Leu11]substance P.
Mitchell FM, Heasley LE, Qian NX, Zamarripa J, Johnson GL. Mitchell FM, et al. J Biol Chem. 1995 Apr 14;270(15):8623-8. doi: 10.1074/jbc.270.15.8623. J Biol Chem. 1995. PMID: 7536738 - Sphingosine-1-phosphate signaling in physiology and diseases.
Takuwa Y, Okamoto Y, Yoshioka K, Takuwa N. Takuwa Y, et al. Biofactors. 2012 Sep-Oct;38(5):329-37. doi: 10.1002/biof.1030. Epub 2012 Jun 7. Biofactors. 2012. PMID: 22674845 Review. - Bombesin receptor antagonists.
de Castiglione R, Gozzini L. de Castiglione R, et al. Crit Rev Oncol Hematol. 1996 Oct;24(2):117-51. doi: 10.1016/1040-8428(96)00220-x. Crit Rev Oncol Hematol. 1996. PMID: 8889369 Review. No abstract available.
Cited by
- International Union of Pharmacology. LXVIII. Mammalian bombesin receptors: nomenclature, distribution, pharmacology, signaling, and functions in normal and disease states.
Jensen RT, Battey JF, Spindel ER, Benya RV. Jensen RT, et al. Pharmacol Rev. 2008 Mar;60(1):1-42. doi: 10.1124/pr.107.07108. Epub 2007 Nov 30. Pharmacol Rev. 2008. PMID: 18055507 Free PMC article. Review. - Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery.
Kenakin T, Miller LJ. Kenakin T, et al. Pharmacol Rev. 2010 Jun;62(2):265-304. doi: 10.1124/pr.108.000992. Epub 2010 Apr 14. Pharmacol Rev. 2010. PMID: 20392808 Free PMC article. Review. - Expression of V1A and GRP receptors leads to cellular transformation and increased sensitivity to substance-P analogue-induced growth inhibition.
MacKinnon AC, Tufail-Hanif U, Lucas CD, Jodrell D, Haslett C, Sethi T. MacKinnon AC, et al. Br J Cancer. 2005 Feb 14;92(3):522-31. doi: 10.1038/sj.bjc.6602366. Br J Cancer. 2005. PMID: 15685238 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous